Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023 - Product Image

Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023

  • ID: 4720657
  • Report
  • Region: Global
  • 111 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care
  • MORE
About this market

The rising partnerships to gain prominence in the market. Vendors are entering into strategic alliances and partnerships for integration of available and emerging technologies into their products. Such partnerships will help the market to grow. The analysts have predicted that the continuous subcutaneous insulin therapy devices market will register a CAGR of more than 9% by 2023.

Market Overview

Rise in awareness about diabetes

The rise in prevalence of diabetes has resulted in increasing awareness efforts by various organizations globally. Programs such as the Diabetes Activities Under State Public Health Actions increase the participation of people.

Rise in product recalls

The growth of the market is hindered by product recalls. Product recalls affect the sales of a company negatively, which results in a decline in it market share. Also, they affect the brand image of vendors, thereby reducing profit margins.

For the detailed list of factors that will drive and challenge the growth of the continuous subcutaneous insulin therapy devices market during the 2019-2023, view the report.

Competitive Landscape

The market appears to be concentrated and with the presence of several companies including Medtronic and Tandem Diabetes Care, the competitive environment is quite intense. Factors such as the rising partnerships and the rise in awareness about diabetes, will provide considerable growth opportunities to continuous subcutaneous insulin therapy devices manufactures. Cellnovo, F. Hoffmann-La Roche, Insulet, Medtronic, and Tandem Diabetes Care are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Tethered - Market size and forecast 2018-2023
  • Patch - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS
  • Technological advances
  • Increase in grants for product development
  • Rise in strategic partnerships
PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Tethered - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Tethered - Year-over-year growth 2019-2023 (%)
Exhibit 21: Patch - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Patch - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in Americas
Exhibit 30: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in EMEA
Exhibit 33: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in APAC
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Decision framework
Exhibit 39: Patients diagnosed with diabetes in US 1995-2015
Exhibit 40: Rates of children aged under 14 years with type 1 diabetes per 1,000 population 2015
Exhibit 41: Product launches
Exhibit 42: Product recalls in global CSITD market
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Cellnovo - Vendor overview
Exhibit 50: Cellnovo - Organizational developments
Exhibit 51: Cellnovo - Geographic focus
Exhibit 52: Cellnovo - Key offerings
Exhibit 53: F. Hoffmann-La Roche - Vendor overview
Exhibit 54: F. Hoffmann-La Roche - Business segments
Exhibit 55: F. Hoffmann-La Roche - Organizational developments
Exhibit 56: F. Hoffmann-La Roche - Geographic focus
Exhibit 57: F. Hoffmann-La Roche - Segment focus
Exhibit 58: F. Hoffmann-La Roche - Key offerings
Exhibit 59: Insulet - Vendor overview
Exhibit 60: Insulet - Organizational developments
Exhibit 61: Insulet - Geographic focus
Exhibit 62: Insulet - Key offerings
Exhibit 63: Medtronic - Vendor overview
Exhibit 64: Medtronic - Business segments
Exhibit 65: Medtronic - Organizational developments
Exhibit 66: Medtronic - Geographic focus
Exhibit 67: Medtronic - Segment focus
Exhibit 68: Medtronic - Key offerings
Exhibit 69: Tandem Diabetes Care - Vendor overview
Exhibit 70: Tandem Diabetes Care - Organizational developments
Exhibit 71: Tandem Diabetes Care - Key offerings
Exhibit 72: Validation techniques employed for market sizing
Exhibit 73: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care
  • MORE
Global Continuous Subcutaneous Insulin Therapy Devices Market 2019-2023

The author of the report recognizes the following companies as the key players in the global continuous subcutaneous insulin therapy devices market: Cellnovo, F. Hoffmann-La Roche, Insulet, Medtronic, and Tandem Diabetes Care.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising partnerships.”

According to the report, one of the major drivers for this market is the rise in awareness about diabetes.

Further, the report states that one of the major factors hindering the growth of this market is the rise in product recalls.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll